SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Astrana Health, Inc. – ‘10-K’ for 12/31/23 – ‘EX-10.59’

On:  Thursday, 2/29/24, at 4:50pm ET   ·   For:  12/31/23   ·   Accession #:  1628280-24-8024   ·   File #:  1-37392

Previous ‘10-K’:  ‘10-K/A’ on 8/9/23 for 12/31/22   ·   Latest ‘10-K’:  This Filing   ·   34 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/29/24  Astrana Health, Inc.              10-K       12/31/23  130:34M                                    Workiva Inc Wde… FA01/FA

Annual Report   —   Form 10-K   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   2.98M 
 2: EX-4.1      Instrument Defining the Rights of Security Holders  HTML     47K 
 3: EX-10.1     Material Contract                                   HTML    150K 
 8: EX-10.11    Material Contract                                   HTML     69K 
 4: EX-10.2     Material Contract                                   HTML     68K 
 5: EX-10.3     Material Contract                                   HTML     68K 
 6: EX-10.4     Material Contract                                   HTML     72K 
 9: EX-10.48    Material Contract                                   HTML    106K 
10: EX-10.49    Material Contract                                   HTML    182K 
 7: EX-10.5     Material Contract                                   HTML     71K 
11: EX-10.54    Material Contract                                   HTML    118K 
12: EX-10.57    Material Contract                                   HTML     62K 
13: EX-10.58    Material Contract                                   HTML     55K 
14: EX-10.59    Material Contract                                   HTML     68K 
15: EX-10.60    Material Contract                                   HTML     99K 
16: EX-10.61    Material Contract                                   HTML     96K 
17: EX-10.62    Material Contract                                   HTML     40K 
18: EX-19.1     Report Furnished to Security Holders                HTML     69K 
19: EX-21.1     Subsidiaries List                                   HTML     36K 
20: EX-23.1     Consent of Expert or Counsel                        HTML     36K 
24: EX-97.1     Clawback Policy re: Recovery of Erroneously         HTML     59K 
                Awarded Compensation                                             
21: EX-31.1     Certification -- §302 - SOA'02                      HTML     40K 
22: EX-31.2     Certification -- §302 - SOA'02                      HTML     40K 
23: EX-32       Certification -- §906 - SOA'02                      HTML     38K 
30: R1          Cover                                               HTML    102K 
31: R2          Audit Information                                   HTML     40K 
32: R3          Consolidated Balance Sheets                         HTML    219K 
33: R4          Consolidated Balance Sheets (Parenthetical)         HTML     85K 
34: R5          Consolidated Statements of Income                   HTML    134K 
35: R6          Consolidated Statements of Mezzanine and            HTML    156K 
                Stockholders? Equity (Deficit)                                   
36: R7          Consolidated Statements of Cash Flows               HTML    210K 
37: R8          Description of Business                             HTML     50K 
38: R9          Basis of Presentation and Summary of Significant    HTML    146K 
                Accounting Policies                                              
39: R10         Business Combinations, Asset Acquisitions, and      HTML     50K 
                Goodwill                                                         
40: R11         Land, Property and Equipment, Net                   HTML     53K 
41: R12         Intangible Assets, Net                              HTML    106K 
42: R13         Investments in Other Entities                       HTML    107K 
43: R14         Loan Receivable and Loan Receivable - Related       HTML     39K 
                Parties                                                          
44: R15         Accounts Payable and Accrued Expenses               HTML     48K 
45: R16         Medical Liabilities                                 HTML     51K 
46: R17         Credit Facility, Bank Loans, and Lines of Credit    HTML     78K 
47: R18         Income Taxes                                        HTML    100K 
48: R19         Mezzanine and Stockholders? Equity (Deficit)        HTML     51K 
49: R20         Stock-Based Compensation                            HTML     79K 
50: R21         Commitments and Contingencies                       HTML     43K 
51: R22         Related-Party Transactions                          HTML     66K 
52: R23         Employee Benefit Plan                               HTML     40K 
53: R24         Earnings Per Share                                  HTML     61K 
54: R25         Variable Interest Entities (VIEs)                   HTML    105K 
55: R26         Leases                                              HTML    118K 
56: R27         Segments                                            HTML    142K 
57: R28         Fair Value Measurements of Financial Instruments    HTML    120K 
58: R29         Subsequent Events                                   HTML     43K 
59: R30         Pay vs Performance Disclosure                       HTML     46K 
60: R31         Insider Trading Arrangements                        HTML     40K 
61: R32         Basis of Presentation and Summary of Significant    HTML    196K 
                Accounting Policies (Policies)                                   
62: R33         Basis of Presentation and Summary of Significant    HTML     61K 
                Accounting Policies (Tables)                                     
63: R34         Business Combinations, Asset Acquisitions, and      HTML     45K 
                Goodwill (Tables)                                                
64: R35         Land, Property and Equipment, Net (Tables)          HTML     52K 
65: R36         Intangible Assets, Net (Tables)                     HTML    173K 
66: R37         Investments in Other Entities (Tables)              HTML    100K 
67: R38         Accounts Payable and Accrued Expenses (Tables)      HTML     48K 
68: R39         Medical Liabilities (Tables)                        HTML     51K 
69: R40         Credit Facility, Bank Loans, and Lines of Credit    HTML     56K 
                (Tables)                                                         
70: R41         Income Taxes (Tables)                               HTML    100K 
71: R42         Stock-Based Compensation (Tables)                   HTML     76K 
72: R43         Related-Party Transactions (Tables)                 HTML     49K 
73: R44         Earnings Per Share (Tables)                         HTML     60K 
74: R45         Variable Interest Entities (VIEs) (Tables)          HTML    102K 
75: R46         Leases (Tables)                                     HTML     92K 
76: R47         Segments (Tables)                                   HTML    134K 
77: R48         Fair Value Measurements of Financial Instruments    HTML    112K 
                (Tables)                                                         
78: R49         Description of Business (Details)                   HTML     44K 
79: R50         Basis of Presentation and Summary of Significant    HTML    101K 
                Accounting Policies - Additional Information                     
                (Details)                                                        
80: R51         Basis of Presentation and Summary of Significant    HTML     50K 
                Accounting Policies - Disaggregation of Revenue by               
                Payor Type (Details)                                             
81: R52         Basis of Presentation and Summary of Significant    HTML     52K 
                Accounting Policies - Contributions to Revenue and               
                Receivables by Payor (Details)                                   
82: R53         Business Combinations, Asset Acquisitions, and      HTML     54K 
                Goodwill - Additional Information (Details)                      
83: R54         Business Combinations, Asset Acquisitions, and      HTML     43K 
                Goodwill - Goodwill Roll Forward (Details)                       
84: R55         Land, Property and Equipment, Net - Schedule of     HTML     70K 
                Land, Property and Equipment, Net (Details)                      
85: R56         Land, Property and Equipment, Net - Additional      HTML     39K 
                Information (Details)                                            
86: R57         Intangible Assets, Net - Schedule of Intangible     HTML    103K 
                Assets (Details)                                                 
87: R58         Intangible Assets, Net - Additional Information     HTML     54K 
                (Details)                                                        
88: R59         Intangible Assets, Net - Schedule of Future         HTML     50K 
                Amortization Expense (Details)                                   
89: R60         Investments in Other Entities - Schedule of Equity  HTML     98K 
                Method Investments (Details)                                     
90: R61         Investments in Other Entities - Narrative           HTML     72K 
                (Details)                                                        
91: R62         Loan Receivable and Loan Receivable - Related       HTML     65K 
                Parties (Details)                                                
92: R63         Accounts Payable and Accrued Expenses (Details)     HTML     53K 
93: R64         Medical Liabilities (Details)                       HTML     58K 
94: R65         Credit Facility, Bank Loans, and Lines of Credit -  HTML     55K 
                Schedule of Credit Facility Information (Details)                
95: R66         Credit Facility, Bank Loans, and Lines of Credit -  HTML     55K 
                Schedule of Maturities (Details)                                 
96: R67         Credit Facility, Bank Loans, and Lines of Credit -  HTML    126K 
                Credit Facility (Details)                                        
97: R68         Credit Facility, Bank Loans, and Lines of Credit -  HTML    102K 
                Lines of Credit (Details)                                        
98: R69         Income Taxes - Income Tax Provision (Benefit)       HTML     57K 
                (Details)                                                        
99: R70         Income Taxes - Provision for Income Taxes           HTML     63K 
                (Details)                                                        
100: R71         Income Taxes - Additional Information (Details)     HTML     49K  
101: R72         Income Taxes - Deferred Tax Assets (Liabilities)    HTML     78K  
                (Details)                                                        
102: R73         Mezzanine and Stockholders? Equity (Deficit) -      HTML     96K  
                Additional Information (Details)                                 
103: R74         Stock-Based Compensation - Additional Information   HTML    116K  
                (Details)                                                        
104: R75         Stock-Based Compensation - Share-Based              HTML     49K  
                Compensation Expense (Details)                                   
105: R76         Stock-Based Compensation - Summary of Stock Option  HTML     79K  
                Activity (Details)                                               
106: R77         Stock-Based Compensation - Summary of Restricted    HTML     65K  
                Stock Activity (Details)                                         
107: R78         Commitments and Contingencies - Additional          HTML     52K  
                Information (Details)                                            
108: R79         Related-Party Transactions - Additional             HTML    133K  
                Information (Details)                                            
109: R80         Related-Party Transactions - Schedule of Related    HTML     53K  
                Party Transactions (Details)                                     
110: R81         Employee Benefit Plan - Additional Information      HTML     40K  
                (Details)                                                        
111: R82         Earnings Per Share - Additional Information         HTML     44K  
                (Details)                                                        
112: R83         Earnings Per Share - Basic Net Income (loss) Per    HTML     52K  
                Share is Calculated Using Weighted Average Number                
                of Shares (Details)                                              
113: R84         Earnings Per Share - Summary of Shares Included in  HTML     54K  
                Diluted Earnings Per Share (Details)                             
114: R85         Variable Interest Entities (VIEs) - Eliminated      HTML    199K  
                Upon Consolidation Included In Accompanying                      
                Consolidated Balance Sheets (Details)                            
115: R86         Leases - Additional information (Details)           HTML     59K  
116: R87         Leases - Components of Lease Expense (Details)      HTML     47K  
117: R88         Leases - Other Information Related to Leases        HTML     60K  
                (Details)                                                        
118: R89         Leases - Future Minimum Payments Under              HTML     83K  
                Non-cancelable Leases After Adoption of 842                      
                (Details)                                                        
119: R90         Segments - Narrative (Details)                      HTML     41K  
120: R91         Segments - Schedule of Information about our        HTML     91K  
                Segments (Details)                                               
121: R92         Fair Value Measurements of Financial Instruments -  HTML    128K  
                Schedule of Carrying Amounts and Fair Values of                  
                Financial Instruments (Details) (Details)                        
122: R93         Fair Value Measurements of Financial Instruments -  HTML     42K  
                Schedule of Change in Fair Value of Level 3                      
                Liabilities (Details) (Details)                                  
123: R94         Fair Value Measurements of Financial Instruments -  HTML    126K  
                Additional Information (Details)                                 
124: R95         Fair Value Measurements of Financial Instruments -  HTML     41K  
                Schedule of Gain (Loss) on Equity Securities                     
                (Details)                                                        
125: R96         Subsequent Events (Details)                         HTML     65K  
127: XML         IDEA XML File -- Filing Summary                      XML    213K  
130: XML         XBRL Instance -- asth-20231231_htm                   XML   3.71M  
126: EXCEL       IDEA Workbook of Financial Report Info              XLSX    269K  
26: EX-101.CAL  XBRL Calculations -- asth-20231231_cal               XML    337K 
27: EX-101.DEF  XBRL Definitions -- asth-20231231_def                XML   1.24M 
28: EX-101.LAB  XBRL Labels -- asth-20231231_lab                     XML   3.14M 
29: EX-101.PRE  XBRL Presentations -- asth-20231231_pre              XML   1.92M 
25: EX-101.SCH  XBRL Schema -- asth-20231231                         XSD    306K 
128: JSON        XBRL Instance as JSON Data -- MetaLinks              795±  1.20M  
129: ZIP         XBRL Zipped Folder -- 0001628280-24-008024-xbrl      Zip   1.18M  


‘EX-10.59’   —   Material Contract


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:   C: 
  Document  
Exhibit 10.59
ASTRANA HEALTH, INC.
EMPLOYMENT INDUCEMENT AWARD PLAN
RESTRICTED STOCK UNIT GRANT NOTICE
Astrana Health, Inc., a Delaware corporation (together with any successor thereof, the “Company”), pursuant to its Employment Inducement Award Plan, as amended from time to time (the “Plan”), hereby grants to the holder listed below (“Participant”) the number of restricted stock units set forth below (individually and collectively referred to as the “RSUs”). The RSUs are subject to all of the terms and conditions set forth herein and in the Restricted Stock Unit Agreement attached hereto as Exhibit A (the “RSU Agreement”) and the Plan, each of which is incorporated herein by reference. Capitalized terms not specifically defined in this Grant Notice shall have the meanings specified in the Plan and/or RSU Agreement, unless the context clearly indicates otherwise.
 
Participant:      
Grant Date:      
Total Number of RSUs:    
Vesting Schedule:  
The RSUs shall vest as follows, subject to Participant’s continuous employment or other service from the Grant Date until the applicable Vesting Date:
Vesting DateNumber of RSUs Vesting

IMPORTANT NOTICE: THE RSU AGREEMENT AND THIS GRANT NOTICE SHALL BE VOID, AND THE RSUS SHALL BE FORFEITED AUTOMATICALLY, IF THIS GRANT NOTICE HAS NOT BEEN SIGNED BY PARTICIPANT AND RETURNED TO THE COMPANY WITHIN 30 DAYS AFTER THE GRANT DATE PROVIDED ABOVE.

[SIGNATURE PAGE FOLLOWS]




By signing below, Participant agrees to be bound by the terms and conditions of the Plan, the RSU Agreement and this Grant Notice. Participant has reviewed the RSU Agreement, the Plan and this Grant Notice in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Grant Notice and fully understands all provisions of this Grant Notice, the RSU Agreement and the Plan. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Company and the Administrator (as defined in the Plan) upon any questions arising under the Plan, this Grant Notice or the RSU Agreement.

IN WITNESS WHEREOF, the undersigned have executed this Grant Notice effective as of the Grant Date set forth above.
 
ASTRANA HEALTH, INC.   PARTICIPANT
By:    By:  
Name: Brandon Sim  Name: 
Title:Chief Executive Officer & President






EXHIBIT A
TO RESTRICTED STOCK UNIT GRANT NOTICE
RESTRICTED STOCK UNIT AGREEMENT
Pursuant to the Restricted Stock Unit Grant Notice (the “Grant Notice”) to which this Restricted Stock Unit Agreement (this “Agreement”) is attached, Astrana Health, Inc., a Delaware corporation (together with any successor thereof, the “Company”), has granted certain restricted stock units (the “RSUs”) to Participant under the Company’s Employment Inducement Plan, as amended from time to time (the “Plan”) as indicated in the Grant Notice.
 
1.
General.
1.1 Defined Terms. Capitalized terms not specifically defined herein shall have the meanings specified in the Plan and/or the Grant Notice, unless the context clearly indicates otherwise.
1.2 Incorporation of Terms of Plan. The RSUs are subject to the terms and conditions of the Plan, which are incorporated herein by reference. In the event of any inconsistency between the Plan and this Agreement or the Grant Notice, the terms of the Plan shall control.
 
2.
Grant.
2.1 Grant of RSUs. In consideration of Participant’s employment with or service to the Company or a Subsidiary and for other good and valuable consideration, effective as of the Grant Date set forth in the Grant Notice (the “Grant Date”), the Company grants to Participant the RSUs, upon the terms and conditions set forth in the Plan, the Grant Notice and this Agreement, subject to adjustments as provided in Article 8 of the Plan. Each RSU represents the contingent right to receive one Share and shall at all times be equal to the value of one Share.
2.2 Consideration to the Company. In consideration of the grant of the RSUs by the Company, Participant agrees to render faithful and efficient services to the Company or a Subsidiary. Nothing in the Plan or this Agreement shall confer upon Participant any right to continue in the employ or service of the Company or any Subsidiary or shall interfere with or restrict in any way the rights of the Company and its Subsidiaries, which rights are hereby expressly reserved, to discharge or terminate the services of Participant at any time for any reason whatsoever, with or without cause, except to the extent expressly provided otherwise in a written agreement between the Company or a Subsidiary and Participant.
 
3.Vesting, Restrictions, Settlement and Etc.
3.1 Vesting. Subject to the terms and conditions of the Plan, the RSUs shall vest at such times and subject to such conditions as are set forth in the Grant Notice; provided, however, that no RSUs that are unvested as of the date of Participant’s termination of employment or service for any reason, with or without cause (including, but not limited to, death, Disability or Retirement), shall thereafter become vested, except as may be otherwise provided by the Administrator or as set forth in a written agreement between the Company and Participant. Notwithstanding any provision of this Agreement to the contrary, in the event of a Change of Control, the treatment of the RSUs will be governed by any applicable provisions of Section 8.2 of the Plan.
3.2 Restrictions. Participant shall have no right to sell, assign, transfer, pledge or otherwise encumber RSUs in any manner. Any purported attempt to sell, assign, transfer, pledge or otherwise encumber any RSUs under this Agreement shall be void and shall result in the



forfeiture and cancellation of such RSUs. Upon Participant’s termination of employment or service for any reason, with or without cause (including, but not limited to, death, Disability or Retirement), any RSUs that are unvested as of the date of such termination of employment or service (and whose vesting is not accelerated pursuant to this Agreement or the Plan) shall be forfeited, and Participant shall have no further rights with respect to such RSUs under this Agreement or otherwise.
3.3 Settlement. The RSUs shall be registered in book entry in the name of Participant until they have vested in accordance with this Agreement. Upon vesting of any of the RSUs, the Company shall deliver the corresponding number of Shares to Participant within 30 days following the date on which such RSUs vested. Upon such delivery to Participant, such Shares will not be subject to any restrictions other than those that may arise under the securities laws or the Company’s policies.
3.4 Tax Withholding. To the extent the Company or any Subsidiary is required to withhold any federal, state, local, foreign or other taxes in connection with the delivery of Shares under this Agreement, then the Company or Subsidiary (as applicable) shall retain a number of Shares otherwise deliverable hereunder with a value equal to the required withholding (based on the Fair Market Value per Share on the applicable date); provided, however, that in no event shall the value of the Shares retained exceed maximum statutory tax rates in the applicable taxing jurisdictions. Notwithstanding the foregoing, to the extent authorized by the Committee, the Participant may be permitted to elect, in accordance with procedures adopted by the Company from time to time, to pay or provide for payment of any required tax withholding. To the extent that the Company or any Subsidiary is required to withhold any federal, state, local, foreign or other taxes at any time other than upon delivery of Shares under this Agreement, the Company, in its discretion may (a) require Participant to pay or provide for payment of the required tax withholding, or (b) satisfy the required tax withholding by deduction from any amount of compensation otherwise payable in cash to Grantee (including any cash dividend equivalent payments pursuant to Section 3.6 of this Agreement).
 
3.5 No Stockholder Rights. Participant shall not possess any incidents of ownership (including, without limitation, dividend and voting rights) in the Shares underlying the RSUs unless and until such Shares have been delivered to Participant in accordance with Section 3.3. The obligations of the Company pursuant to this Agreement are merely that of an unfunded and unsecured promise of the Company to deliver Shares (and cash dividend equivalents, if any, pursuant to Section 3.6 hereof) in the future and subject to the terms and conditions of this Agreement, and the rights of Participant hereunder are no greater than those of an unsecured general creditor. No Company assets shall be held or set aside as security for the Company’s obligations pursuant to this Agreement.
3.6 Dividend Equivalents. From and after the Grant Date and until the earlier of (a) the time when the Shares underlying the vested RSUs (if any) are delivered to Participant in accordance with this Agreement, or (b) the time that the RSUs are forfeited in accordance with this Agreement, on each date, if any, that the Company pays a cash dividend to holders of its Shares generally, the Company will credit Participant’s account hereunder with the right to receive a cash amount equal to the product of (x) the dollar amount of the cash dividend paid per Share to stockholders on such date multiplied by (y) the total number of unpaid RSUs credited to Participant’s account under this Agreement as of such date. Subject to and conditioned upon the vesting of the underlying RSUs, the aggregate amount of any such dividend equivalents credited to Participant’s account hereunder shall be paid to Participant in cash (without interest), at the same time and in the same proportion that the Shares underlying any vested RSUs are delivered to Participant, and the Participant’s right to receive any such dividend equivalents shall be automatically and correspondingly forfeited to the extent that the RSUs are forfeited pursuant to the terms of this Agreement and the Plan.
2



3.7 Compensation Recovery Policy. The RSUs and any Shares that may be delivered pursuant to this Agreement are subject to forfeiture or repayment as may be provided pursuant to the Company’s Compensation Recovery Policy (or any successor compensation recovery policy), as in effect from time to time.
4.
Other Provisions.
4.1 Administration. The Administrator has the authority to take all actions and make all determinations under the Plan, to interpret the Plan, the Grant Notice, and this Agreement, and to adopt, amend and repeal Plan administrative rules, guidelines and practices as it deems advisable. The Administrator may correct defects and ambiguities, supply omissions and reconcile inconsistencies in the Plan, the Grant Notice or this Agreement as it deems necessary or appropriate to administer the Plan, the Grant Notice and this Agreement. The Administrator’s determinations under the Plan are in its sole discretion and will be final and binding on all persons having or claiming any interest in the Plan or any Award.
4.2 Adjustments Upon Specified Events. The Administrator may accelerate the vesting of all or a portion the RSUs in such circumstances as it, in its sole discretion, may determine. Participant acknowledges that the RSUs are subject to adjustment, modification and termination in certain events as provided in this Agreement and the Plan.
4.3 Notices. Any notice to be given under the terms of this Agreement to the Company shall be addressed to the Company in care of the Secretary of the Company (or any other person or entity as designated by the Administrator) at the Company’s principal office, and any notice to be given to Participant shall be addressed to Participant at Participant’s last address reflected on the Company’s records. By a notice given pursuant to this Section 4.3, either party may hereafter designate a different address for notices to be given to that party. A notice shall be deemed duly given when sent via email or when sent by certified mail (return receipt requested) and deposited (with postage prepaid) in a post office or branch post office regularly maintained by the United States Postal Service.
 
4.4 Titles and Headings. Titles are provided herein for convenience only and are not to serve as a basis for interpretation or construction of this Agreement.

4.5 Governing Law. The laws of the State of Delaware, without reference to any conflict of law principles thereof, shall govern the interpretation, validity, administration, enforcement and performance of the terms of this Agreement.
4.6 Conformity to Laws. Participant acknowledges that the Plan, the Grant Notice and this Agreement are intended to conform to the extent necessary with all provisions of the Securities Act of 1933, as amended, the Exchange Act and the Code, and any and all regulations and rules promulgated thereunder, state securities laws and regulations and all other applicable law. Notwithstanding anything herein to the contrary, the Plan shall be administered, and the RSUs are granted and shall be administered, only in such a manner as to conform to such laws, rules and regulations. To the extent permitted by applicable law, the Plan, the Grant Notice and this Agreement shall be deemed amended to the extent necessary to conform to such laws, rules and regulations.
4.7 Section 409A of the Code. The Award of RSUs evidenced by this Agreement is intended to be exempt from, or to comply with, the requirements of Section 409A of the Code, and this Agreement shall be interpreted and administered in accordance with such intent. Accordingly, solely to the extent necessary to comply with the requirements of Section 409A of the Code: (a) the termination of Participant’s employment or other service shall be interpreted to mean the Participant’s “separation from service” within the meaning of Section 409A of the Code; (b) if Participant is a “specified employee” (as determined by the Company in accordance
3



with Section 409A of the Code), settlement of any vested RSUs (and payment of any related dividend equivalents) as a result of Participant’s separation from service shall be delayed until the first business day that is at least six months after the date of Participant’s separation from service or, if earlier, the date of Participant’s death; and (c) a Change of Control shall be interpreted to mean an event that qualifies as both a “Change of Control” as defined in the Plan and a “change in control event” within the meaning of Section 409A of the Code and Treasury Regulation §1.409A-3(i)(5). Notwithstanding the foregoing, the tax treatment of the RSUs is not warranted or guaranteed. Neither the Company and its Subsidiaries, nor their respective affiliates, directors, officers, employees and advisers shall be held liable for any taxes, interest, penalties or other monetary amounts that may owed by the Participant or other taxpayer as a result of the Award of RSUs or this Agreement.
4.8 Amendments, Suspension and Termination. To the extent permitted by the Plan, the Grant Notice and this Agreement may be wholly or partially amended or otherwise modified, suspended or terminated at any time or from time to time by the Committee or the Board; provided, however, that except as may otherwise be provided by the Plan or Section 4.6 of this Agreement, no amendment, modification, suspension or termination of this Agreement shall adversely affect the RSUs in any material way without the prior written consent of Participant.
4.9 Successors and Assigns. The Company may assign any of its rights under this Agreement to single or multiple assignees, and this Agreement shall inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer set forth in Section 3.2 hereof, this Agreement shall be binding upon Participant and his or her heirs, executors, administrators, successors and assigns.
4.10 Not a Contract of Employment. Nothing in this Agreement, the Grant Notice or in the Plan shall confer upon Participant any right to continue to serve as an employee or other service provider of the Company or any of its Subsidiaries or affiliates.
4.11 Relation to Other Benefits. Any economic or other benefit to Participant under this Agreement or the Plan shall not be taken into account in determining any benefits to which Participant may be entitled under any profit-sharing, retirement or other benefit or compensation plan maintained by the Company or any of its Subsidiaries or affiliates, except as expressly provided in writing in such other plan’s governing instrument.
4.12 Data Privacy. In order to administer the Plan, the Company may process personal data about Participant. Such data includes, but is not limited to, the information provided in this Agreement and any changes thereto, other appropriate personal and financial data about Participant such as home address and business addresses and other contact information, and any other information that might be deemed appropriate by the Company to facilitate the administration of the Plan. Participant hereby gives explicit consent to the Company to process any such personal data. Participant also gives explicit consent to the Company to transfer any such personal data outside the country in which Participant works or is employed, including, if Participant is not a U.S. resident, to the United States, to transferees that shall include the Company and other persons who are designated by the Company to administer the Plan.
4.13 Electronic Delivery. Participant hereby consents and agrees to electronic delivery of any documents that the Company may elect to deliver, including, but not limited to, the Plan document, Plan Summary and Prospectus, grant or award notifications, account statements, annual and quarterly reports, and all other forms of communications (“Prospectus Information”) in connection with this and any other Award made or offered under the Plan. Participant has the right at any time to request that the Company deliver written copies of any and all Prospectus Information at no charge. Participant also hereby consents to any and all procedures the Company has established or may establish for an electronic signature system for delivery and acceptance of any such Prospectus Information that the Company may elect to deliver and agrees
4



that Participant’s electronic response or signature is the same as, and shall have the same force and effect as, Participant’s manual signature.
4.14 Entire Agreement. The Plan, the Grant Notice and this Agreement (including any Exhibits to any of the foregoing) constitute the entire agreement of the parties and supersede in their entirety all prior undertakings and agreements of the Company and Participant with respect to the subject matter hereof.

[END OF DOCUMENT]
5


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:2/29/248-K
For Period end:12/31/23
 List all Filings 


1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/09/24  Astrana Health, Inc.              10-Q        3/31/24  100:13M                                    Workiva Inc Wde… FA01/FA


33 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/29/24  Astrana Health, Inc.              8-K:5,8,9   2/28/24   12:594K                                   Toppan Merrill/FA
 2/02/24  Apollo Medical Holdings, Inc.     8-K:3,8,9   1/31/24   11:316K                                   Toppan Merrill/FA
 1/26/24  Apollo Medical Holdings, Inc.     8-K:5,8,9   1/25/24   11:197K                                   Toppan Merrill/FA
 1/02/24  Apollo Medical Holdings, Inc.     8-K:8,9    12/26/23   11:275K                                   Toppan Merrill/FA
11/17/23  Apollo Medical Holdings, Inc.     8-K:5,9    11/15/23   13:410K                                   Toppan Merrill/FA
11/07/23  Apollo Medical Holdings, Inc.     8-K:1,2,9  11/03/23   12:2.8M                                   Toppan Merrill/FA
11/07/23  Apollo Medical Holdings, Inc.     8-K:1,9    11/06/23   11:251K                                   Toppan Merrill/FA
11/07/23  Apollo Medical Holdings, Inc.     8-K:1,8,9  11/07/23   13:1.7M                                   Toppan Merrill/FA
 9/08/23  Apollo Medical Holdings, Inc.     8-K:1,2,9   9/08/23   11:257K                                   Toppan Merrill/FA
 3/01/23  Apollo Medical Holdings, Inc.     10-K       12/31/22  108:72M                                    Workiva Inc Wde… FA01/FA
 8/09/22  Apollo Medical Holdings, Inc.     10-Q        6/30/22   92:18M                                    Workiva Inc Wde… FA01/FA
 8/06/21  Apollo Medical Holdings, Inc.     10-Q        6/30/21   89:13M                                    Workiva Inc Wde… FA01/FA
 8/10/20  Apollo Medical Holdings, Inc.     10-Q        6/30/20   95:15M                                    Workiva Inc Wde… FA01/FA
 5/06/20  Apollo Medical Holdings, Inc.     8-K:2,9     4/30/20    3:930K                                   Toppan Merrill/FA
 9/30/19  Apollo Medical Holdings, Inc.     8-K:5,7,8,9 9/29/19    3:166K                                   Toppan Merrill/FA
 9/12/19  Apollo Medical Holdings, Inc.     8-K:1,2,3,7 9/11/19   12:1.6M                                   Toppan Merrill/FA
 8/29/19  Apollo Medical Holdings, Inc.     8-K:1,2,3,5 8/26/19    4:212K                                   Toppan Merrill/FA
 5/13/19  Apollo Medical Holdings, Inc.     8-K:1,2,3,8 5/10/19   11:1M                                     Toppan Merrill/FA
 5/10/19  Apollo Medical Holdings, Inc.     10-Q        3/31/19   80:16M                                    Toppan Merrill/FA
 1/17/19  Apollo Medical Holdings, Inc.     8-K:5,7,8,9 1/11/19    4:251K                                   Edgar Filing LLC/FA
 6/21/18  Apollo Medical Holdings, Inc.     8-K:5,9     6/18/18    3:55K                                    Toppan Merrill/FA
 4/02/18  Apollo Medical Holdings, Inc.     10-K       12/31/17  114:13M                                    Toppan Merrill/FA
12/13/17  Apollo Medical Holdings, Inc.     8-K:1,2,3,512/07/17    6:181K                                   Toppan Merrill/FA
11/15/17  Apollo Medical Holdings, Inc.     424B3                  1:6.8M                                   Toppan Merrill/FA
10/20/17  Apollo Medical Holdings, Inc.     8-K:1,2,3,910/16/17    4:118K                                   Toppan Merrill/FA
 4/04/16  Apollo Medical Holdings, Inc.     8-K:1,3,5,7 3/30/16    5:4M                                     Toppan Merrill/FA
 1/19/16  Apollo Medical Holdings, Inc.     8-K:5,7,9   1/12/16    8:14M                                    Toppan Merrill/FA
10/19/15  Apollo Medical Holdings, Inc.     8-K:1,3,5,710/14/15    5:10M                                    Toppan Merrill/FA
 4/27/15  Apollo Medical Holdings, Inc.     8-K:3,5,9   4/24/15    3:59K                                    Toppan Merrill/FA
 1/21/15  Apollo Medical Holdings, Inc.     8-K:8,9     1/16/15    3:163K                                   Toppan Merrill/FA
12/08/14  Apollo Medical Holdings, Inc.     8-K/A:1,9   7/21/14    2:117K                                   Toppan Merrill/FA
11/14/14  Apollo Medical Holdings, Inc.     10-Q        9/30/14   76:10M                                    Toppan Merrill/FA
 5/08/14  Apollo Medical Holdings, Inc.     10-K        1/31/14  109:14M                                    Toppan Merrill/FA
Top
Filing Submission 0001628280-24-008024   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 7:46:20.2am ET